National Storage Mechanism | Additional information
Faron Pharmaceuticals
08 Aug 2025 14:00 UTC
Faron Pharmaceuticals Ltd: Holding(s) in Company
Faron Pharmaceuticals Ltd | Company announcement | August 08, 2025 at 17:00:00 EEST
TR-1: Standard form for notification of major holdings
|
|
|
|
|
| NOTIFICATION OF MAJOR HOLDINGS |
|
|
|
|
|
|
|
|
|
| 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: |
|
|
Faron Pharmaceuticals Ltd |
|
| 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) |
|
|
|
|
| Non-UK issuer |
|
|
|
|
| 2. Reason for the notification (please mark the appropriate box or boxes with an “X”) |
|
|
|
|
| An acquisition or disposal of voting rights |
|
|
|
|
| An acquisition or disposal of financial instruments |
|
|
|
|
| An event changing the breakdown of voting rights |
|
|
|
|
| Other (please specify) iii: Change due theAdvanced Amortisation of the First Tranche Bonds |
|
|
|
|
| 3. Details of person subject to the notification obligation iv |
|
|
|
|
| Name |
|
|
Timo Syrjälä |
|
| City and country of registered office (if applicable) |
|
|
Monaco |
|
| 4. Full name of shareholder(s) (if different from 3.) v |
|
|
|
|
| Name |
|
|
|
|
| City and country of registered office (if applicable) |
|
|
|
|
| 5. Date on which the threshold was crossed or reached vi: |
|
|
07/08/2025 |
|
| 6. Date on which issuer notified (DD/MM/YYYY): |
|
|
08/02/2025 |
|
| 7. Total positions of person(s) subject to the notification obligation |
|
|
|
|
|
% of voting rights attached to shares (total of 8. A) |
% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2) |
|
Total of both in % (8.A + 8.B) |
| Resulting situation on the date on which threshold was crossed or reached |
14.997% |
|
|
14.997% |
Position of previous notification (if
applicable) |
15.15% |
|
|
15.15% |
|
|
|
|
|
|
| 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii |
|
|
|
|
|
| A: Voting rights attached to shares |
|
|
|
|
|
Class/type ofshares
ISIN code (if possible) |
|
Number of voting rights ix |
|
|
|
Direct
(DTR5.1) |
|
Indirect
(DTR5.2.1) |
|
|
Direct
(DTR5.1) |
| FI4000153309 |
|
5,330,368 |
|
11,588,028 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| SUBTOTAL 8. A |
|
16,918,396 |
|
|
|
|
|
|
|
|
|
| B 1: Financial Instruments according to DTR5.3.1R (1) (a) |
|
|
|
|
|
| Type of financial instrument |
|
Expirationdate x |
Exercise/Conversion Period xi |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SUBTOTAL 8. B 1 |
|
|
|
|
|
|
|
|
| B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b) |
|
|
|
|
|
| Type of financial instrument |
Expirationdate x |
|
Exercise/Conversion Period xi |
|
Physical or cash
Settlement xii |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SUBTOTAL 8.B.2 |
|
|
|
|
|
|
|
|
|
|
9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an “X”) |
|
|
|
| Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii |
|
|
|
Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv |
|
|
|
| Name xv |
% of voting rights if it equals or is higher than the notifiable threshold |
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold |
Total of both if it equals or is higher than the notifiable threshold |
| Timo Syrjälä (Direct) |
4.73% |
|
4.73% |
| Acme Investments SPF Sarl (Indirect) |
10.27% |
|
10.27% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 10. In case of proxy voting, please identify: |
|
|
|
| Name of the proxy holder |
|
|
|
| The number and % of voting rights held |
|
|
|
| The date until which the voting rights will be held |
|
|
|
|
|
|
|
| 11. Additional information xvi |
|
|
|
| Faron Advanced Amortisation of the First Tranche Bonds 07.08.2025 |
|
|
|
|
|
| Place of completion |
Monaco |
| Date of completion |
08/08/2025 |
MFN is a regulatory news distribution service and it is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. The service is built to easily manage all the tasks of news distribution for listed companies.
For further information, please contact [email protected] or visit Modular Finance.
View the source version on MFN: Faron Pharmaceuticals Ltd: Holding(s) in Company